Chronic Daily Headache
12
2
2
7
Key Insights
Highlights
Success Rate
78% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
16.7%
2 terminated out of 12 trials
77.8%
-8.7% vs benchmark
17%
2 trials in Phase 3/4
43%
3 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (12)
Multi-center RCT of IV Ketamine Efficacy and Safety in Chronic Daily Headaches
Analysis of Headache Chronification With Imaging, Deep Phenotyping, and Proteomics
Do Patients With Chronic Daily Headache Have Continuous Headache or Moments of Headache Relief?
Sphenopalatine Ganglion Nerve Block vs. Elavil for Treatment of Transformed Migraines
Effect of Intranasal Oxytocin on Headache in Chronic Daily Headache
Assessment of the Efficacy of the Transnasal Sphenopalatine Ganglion Block in the Treatment of Chronic Daily Headache in Children and Adolescents.
Offset Analgesia as a Measure of Central Sensitization in Children
Propofol Injection for Daily Headache
Yoga Training for Returning Veterans With Headache
Nutrition for Chronic Daily Headache
Intensive Meditation and Migraines: Effects on Health and Well Being
Atkins Diet for Difficult-to-Control Headaches in Teenagers